SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 643.94+2.5%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: A.J. Mullen who wrote (3375)9/19/2021 11:04:14 PM
From: CuttingEdge Bio  Read Replies (1) of 3557
 
But almost all people who are double vaxxed have antibodies and will be seropositive on any test.
And the immunocompromised make up the rare exceptions, but you already know they need to be treated because they're immunocompromised.
It is the very old, 75 year olds with way too much residual covid mortality risk in a breakthrough infection, who will undoubtedly be seropositive even before they are infected, but there needs to be some metric to say they need or don't need treatment.
Or just approve giving it based on age!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News